184 related articles for article (PubMed ID: 2373860)
1. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
5. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
Agrawal B; Fraga E; Kane K; Singh B
J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
[TBL] [Abstract][Full Text] [Related]
8. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
[TBL] [Abstract][Full Text] [Related]
9. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
10. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
11. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
13. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
15. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
[TBL] [Abstract][Full Text] [Related]
16. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules.
Castellino F; Zappacosta F; Coligan JE; Germain RN
J Immunol; 1998 Oct; 161(8):4048-57. PubMed ID: 9780175
[TBL] [Abstract][Full Text] [Related]
17. Role of newly synthesized MHC class II molecules in antigen-specific antigen presentation by B cells.
Kokuho T; Nariuchi H; Gyotoku Y; Kakiuchi T
Immunobiology; 1995 Jun; 193(1):42-58. PubMed ID: 7590862
[TBL] [Abstract][Full Text] [Related]
18. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
19. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
20. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
